In vivo treatment of HCV core-positive HepG2 cells with the transfer of recombinant caspase-3 using a 2'-5' OAS promoter

Author:          

Publisher: Spandidos Publications

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.5, Iss.3, 2012-01, pp. : 631-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract